source
- Strategic steps for moving sterile injectables from lab to clinical trialsThe article, sponsored by Vetter, discusses how drug owners of sterile injectable candidates face a key question when a molecule is ready for first‑in‑human studies: how fast can a clinical batch b…
- Rapport Therapeutics says it is ready to launch its seizure drug independentlyIn a recent interview, CEO Abe Ceesay explained that Rapport Therapeutics has assembled an investor syndicate and feels fully prepared to bring its seizure drug to market on its own. Founded in 20…